204 related articles for article (PubMed ID: 23256719)
21. Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities.
Thomson NC
Curr Opin Pharmacol; 2018 Jun; 40():1-8. PubMed ID: 29223018
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
23. Use of mucolytics in COPD: A Delphi consensus study.
Papi A; Avdeev S; Calverley PMA; Cordeiro CR; Jesenak M; Koblížek V; Petkova D; Rogliani P; Tarraf H; Tzanakis N; Ulmeanu R; Uzaslan E; Adir Y
Respir Med; 2020 Dec; 175():106190. PubMed ID: 33217537
[TBL] [Abstract][Full Text] [Related]
24. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
25. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
26. The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease.
Wang XL; Li T; Li JH; Miao SY; Xiao XZ
Molecules; 2017 Sep; 22(9):. PubMed ID: 28895883
[TBL] [Abstract][Full Text] [Related]
27. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
28. Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease.
Ahmad A; Shameem M; Husain Q
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1104-9. PubMed ID: 23827037
[TBL] [Abstract][Full Text] [Related]
29. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
Lin JL; Thomas PS
COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
[TBL] [Abstract][Full Text] [Related]
31. COPD: balancing oxidants and antioxidants.
Fischer BM; Voynow JA; Ghio AJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():261-76. PubMed ID: 25673984
[TBL] [Abstract][Full Text] [Related]
32. Role of mucolytics in the management of COPD.
Poole PJ
Int J Chron Obstruct Pulmon Dis; 2006; 1(2):123-8. PubMed ID: 18046889
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress in COPD.
Kirkham PA; Barnes PJ
Chest; 2013 Jul; 144(1):266-273. PubMed ID: 23880677
[TBL] [Abstract][Full Text] [Related]
34. Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases.
Macciò A; Madeddu C; Panzone F; Mantovani G
Expert Opin Pharmacother; 2009 Mar; 10(4):693-703. PubMed ID: 19239402
[TBL] [Abstract][Full Text] [Related]
35. Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: Results of a placebo-controlled trial.
Dal Negro RW; Visconti M
Pulm Pharmacol Ther; 2016 Dec; 41():48-51. PubMed ID: 27651323
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
Kirkil G; Hamdi Muz M; Seçkin D; Sahin K; Küçük O
Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
[TBL] [Abstract][Full Text] [Related]
37. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant.
Sadowska AM; van Overveld FJ; Górecka D; Zdral A; Filewska M; Demkow UA; Luyten C; Saenen E; Zielinski J; De Backer WA
Respir Med; 2005 Feb; 99(2):241-9. PubMed ID: 15715193
[TBL] [Abstract][Full Text] [Related]
38. The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data.
Cazzola M; Floriani I; Page CP
Pulm Pharmacol Ther; 2010 Apr; 23(2):135-44. PubMed ID: 19854285
[TBL] [Abstract][Full Text] [Related]
39. [Effect of PM2.5 on the level of nuclear factor erythroid-2 related factor 2 in chronic obstructive pulmonary disease mice and its relationship with oxidative stress].
Zhao QJ; Liu XJ; Zeng XL; Bao HR
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2241-5. PubMed ID: 27480657
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
